For patients with nontraumatic, out-of-hospital cardiac arrest (OHCA), evolving technology in the form of resuscitative endovascular balloon occlusion of the aorta, as well as expanded use of ...
U.S. Department of Defense awards Prytime Medical grant to study the clinical outcomes of the world's first and only catheter designed for Partial REBOA, pREBOA-PRO™ "Partial REBOA delivered with ...
U.S. Army Medical Research and Development Command Funds FORCE Study to Evaluate Advanced Hemorrhage Control Technology on the Battlefield - Prytime Medical SAN ANTONIO, Nov. 1, 2024 /PRNewswire/ -- ...
For trauma patients with exsanguinating torso hemorrhage, resuscitative endovascular balloon occlusion of the aorta (REBOA) did not reduce mortality, and may have increased 90-day mortality, when ...
A new technique used to control severe bleeding in injured patients has been found to likely increase the risk of death, according to new research from the University of Aberdeen. The world's first ...
SAN ANTONIO, Nov. 1, 2024 /PRNewswire/ -- The U.S. Army Medical Research and Development Command has announced a new study that will assess the efficacy of the new 2+ hour pREBOA-PROTM catheter in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results